Choose your language
Traditional Chinese
Simplified Chinese


The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far! - Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Centre
Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate a pharmacovigilance strategy locally. - Director of Regulatory Affairs, Nycomed China
The topics discussed in this conference are simple enough for a beginner and complex enough for the experienced. Brilliant! - Senior Safety Officer, GSK
Very valuable conference & excellent sharing of pharmacovigilance experiences and best practices ? Country Safety Head, Pfizer
Very well organised conference! Attendee mix was nice ? including industry and regulators! Well done! - Head, Lifesciences EU & APAC, Cognizant
This conference offers the opportunity for those working in pharmacovigilance to share expertise and learn about best practices and challenge the way they do things. - Pharmacovigilance manager, MSD
Good discussions and good comments from all representatives and speakers! - CPM, EPS International


Gii Event
이벤트 캘린더
파머슈티컬 관련 국제컨퍼런스

파머슈티컬 관련 국제컨퍼런스

메일링 서비스
메일링 서비스

4th Annual Pharmacovigilance Asia 2013 - 제4회 약물감시 아시아 2013 -
2013년 6월 18 - 21일, 싱가포르 Amara Hotel

2013년 컨퍼런스 연사

 Kelly Teo
Kelly Teo
Regional Pharmacovigilance Lead, Asia Pacific
Dr. Abhay Chimankar
Global Safety Officer
Shinichi Nishiuma
Vice President, Japanese Association of Pharmaceutical Medicine, Senior Medical Advisor, Senior Manager, Surveillance and Epidemiology, Global Dr Efraim Ariesandy Patient Safety
Eli Lilly Japan
 Dr. Ji Ming
Dr. Ji Ming
Senior Medical Director in Clinical Safety Evaluation, Global Pharmacovigilance
 Timothé Menard
Timothé Menard
Safety Area Manager, APAC
Merck Serono

Updates from Regulatory Bodies Including:

  • Dr.Wenmin Du, Executive Director, Shanghai Centre for Adverse Drug Reaction Monitoring, SFDA
  • Dr Y K Gupta, National Scientific Coordinator, Pharmacovigilance program of India
  • Dra. A. RetnoTyasUtami, Apt.M. Epid, Deputy Director, Therapeutic Products, Narcotic, Psychotropic and Addictive Substances, BPOM Indonesia
  • Mohamad Khalid Haji Zolkipli, National Adverse Drug Reaction Monitoring Centre, Department of Pharmaceutical Services, Ministry of Health Brunei Darussalam
  • Senior Representative, Korea FDA

Other Regulatory Bodies Attending:

  • Health Sciences Authority Singapore
  • FDA, Thailand
  • National Pharmaceutical Control Bureau Malaysia
  • Food & Drug Development, Lao PDR
  • National Centre for Drug Information and ADR Reporting, Vietnam

법규제 요구사항을 준수하면서 리스크 관리, 감사, 사찰 및 약물유해반응 관리 전략을 시행하기 위한 실용적인 조언 제공

"약물감시는 차기 ICDRA의 주제이며, 증가하는 다양한 안전성 요구에 대처하기 위해 의료 제도 내에 약물감시 시스템을 구축하기 위한 제안을 강화합니다."

- 세계보건기구(WHO)

약물감시 감사에 꼭 성공해야 하시나요?

이런 생각을 가지고 있다면 리스크 관리 계획과 다양한 약물감시에 관한 아시아의 법규제가 일상 업무에 미치는 영향에 대해 많은 조언이 필요합니다.

제4회 Pharmacovigilance Asia Summit에는 직면하는 최대 문제를 극복하기 위해 약물감시 전문가가 참가합니다.

Join Us Now And Benefit By Learning From:

  • 13 industry best practice case studies to empower you with proven successful strategies on risk management planning, ADR reporting and monitoring, regulatory compliance, audit and inspection preparation
  • Best practice case studies on developing effective risk management plans and PSURs pre and post marketing
  • Industry secrets that will help you best prepare for a pharmacovigilance audit and inspection

주요 컨퍼런스 하이라이트

  • 패널 디스커션에서는 세계적인 안전성 요건을 충족시키면서 국가별 법규제를 준수하기 위한 약물감시 전략 운영의 실용적 힌트 제공
  • 중국, 인도네시아, 인도를 비롯한 각국의 최신 법규제 동향과 아시아 법규제 기관 인사와의 상세한 논의와 교류가 가능한 토론회 마련
  • 효과적인 리스크 관리 계획 수립과 시판 전후 PSUR에 관한 베스트 프랙티스 사례 연구
  • 약물감시 감사를 위한 업계내 비결 소개
  • 이상 반응 데이터의 회수, 사정, 평가를 촉진하는 방법에 관한 약물감시 실무담당자의 의견 소개

» 전체 참가자 안내

Sponsors & Exhibitors
Aris Global
Lambda Therapeutic Research
Media Partners
Pharma IQ
Asia Monitor
Biospectrum Asia
Pan-Asian Clinical Research Association (PACRA)
Pharmaceutical and Healthcare Association of Philippines (PHAP)
Pharma Focus Asia
Pharma Koreana
Pharmacovigilance India (OviyaMedSafe3)